Pursuant to the commitment letters, the lenders have committed to provide Teva up to $27,000,000,000 in loans under a senior unsecured Bridge Loan Credit Facility and up to $6,750,000,000 in loans under an Equity Bridge Loan Credit Facility. The commitments of the lenders are subject to customary conditions, including the negotiation of definitive financing agreements and other conditions as set forth in the commitment letters.